Airway remodelling in asthma: From benchside to clinical practice

被引:242
作者
Bergeron, Celine [2 ]
Tulic, Meri K. [3 ]
Hamid, Qutayba [1 ]
机构
[1] McGill Univ, Meakins Christie Labs, Montreal, PQ H2X 2P2, Canada
[2] Univ Montreal, Ctr Hosp Univ Montreal, Hotel Dieu Hosp, Montreal, PQ, Canada
[3] Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Div Cell Biol, Perth, WA, Australia
基金
英国医学研究理事会;
关键词
Allergy; Asthma; Remodelling; Rhinitis; RETICULAR BASEMENT-MEMBRANE; HUMAN BRONCHIAL FIBROBLASTS; SUBEPITHELIAL COLLAGEN DEPOSITION; LEUKOTRIENE RECEPTOR ANTAGONIST; SMOOTH-MUSCLE PROLIFERATION; MESSENGER-RNA EXPRESSION; INDEPENDENT RISK-FACTOR; ALLERGIC RHINITIS; INHALED CORTICOSTEROIDS; MURINE MODEL;
D O I
10.1155/2010/318029
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Airway remodelling refers to the structural changes that occur in both large and small airways relevant to miscellaneous diseases including asthma. In asthma, airway structural changes include subepithelial fibrosis, increased smooth muscle mass, gland enlargement, neovascularization and epithelial alterations. Although controversial, airway remodelling is commonly attributed to an underlying chronic inflammatory process. These remodelling changes contribute to thickening of airway walls and, consequently, lead to airway narrowing, bronchial hyper-responsiveness, airway edema and mucous hypersecretion. Airway remodelling is associated with poor clinical outcomes among asthmatic patients. Early diagnosis and prevention of airway remodelling has the potential to decrease disease severity, improve control and prevent disease expression. The relationship between structural changes and clinical and functional abnormalities clearly deserves further investigation. The present review briefly describes the characteristic features of airway remodelling observed in asthma, its clinical consequences and relevance for physicians, and its modulation by therapeutic approaches used in the treatment of asthmatic patients.
引用
收藏
页码:E85 / E93
页数:9
相关论文
共 132 条
[81]   Matrix metalloproteinase-9 expression in asthma - Effect of asthma severity, allergen challenge, and inhaled corticosteroids [J].
Mattos, W ;
Lim, S ;
Russell, R ;
Jatakanon, A ;
Chung, F ;
Barnes, PJ .
CHEST, 2002, 122 (05) :1543-1552
[82]   Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics [J].
Mautino, G ;
Oliver, N ;
Chanez, P ;
Bousquet, J ;
Capony, F .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (05) :583-591
[83]   Mast cells [J].
Metcalfe, DD ;
Baram, D ;
Mekori, YA .
PHYSIOLOGICAL REVIEWS, 1997, 77 (04) :1033-1079
[84]   On the functional consequences of bronchial basement membrane thickening [J].
Milanese, M ;
Crimi, E ;
Scordamaglia, A ;
Riccio, A ;
Pellegrino, R ;
Canonica, GW ;
Brusasco, V .
JOURNAL OF APPLIED PHYSIOLOGY, 2001, 91 (03) :1035-1040
[85]   Treatment of allergic asthma with monoclonal anti-IgE antibody [J].
Milgrom, H ;
Fick, RB ;
Su, JQ ;
Reimann, JD ;
Bush, RK ;
Watrous, ML ;
Metzger, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1966-1973
[86]   IL-11 expression is increased in severe asthma: Association with epithelial cells and eosinophils [J].
Minshall, E ;
Chakir, J ;
Laviolette, M ;
Molet, S ;
Zhu, Z ;
Olivenstein, R ;
Elias, JA ;
Hamid, Q .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (02) :232-238
[87]   Eosinophil-associated TGF-beta(1) mRNA expression and airways fibrosis in bronchial asthma [J].
Minshall, EM ;
Leung, DYM ;
Martin, RJ ;
Song, YL ;
Cameron, L ;
Ernst, P ;
Hamid, Q .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (03) :326-333
[88]   IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines [J].
Molet, S ;
Hamid, Q ;
Davoine, F ;
Nutku, E ;
Taha, R ;
Pagé, N ;
Olivenstein, R ;
Elias, J ;
Chakir, J .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (03) :430-438
[89]   THE SITE OF DISRUPTION OF THE BRONCHIAL EPITHELIUM IN ASTHMATIC AND NONASTHMATIC SUBJECTS [J].
MONTEFORT, S ;
ROBERTS, JA ;
BEASLEY, R ;
HOLGATE, ST ;
ROCHE, WR .
THORAX, 1992, 47 (07) :499-503
[90]  
MOSMANN TR, 1986, J IMMUNOL, V136, P2348